KOKH kliinilised uuringud osariigis Missouri
7 uuringut haiguse KOKH jaoks otsivad osalejaid osariigis Missouri.
Linnad osariigis Missouri
Ametlik uuringutekst (inglise keeles)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, St Louis
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 2. okt 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- University of Missouri Health Care - Children's Hospital- Site Number : 8400150, Columbia
- Hannibal Regional Healthcare System- Site Number : 8400035, Hannibal
- Washington University- Site Number : 8400144, St Louis
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 1. okt 2026 · NCT07190222Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Midwest Chest Consultants, P.C., Saint Charles
VärbamineFaas 4
Vanused 60 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07816835A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Chesterfield
- Research Site, Hannibal
- Research Site, St Louis
- ja veel 1
VärbamineFaas 2
Vanused 40 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Hannibal
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 3. sept 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, St Louis
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 3. sept 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Washington University School of Medicine, St Louis
- Barnes-Jewish Hospital Investigational Drug Service, St Louis
- Barnes-Jewish Hospital, St Louis
- ja veel 2
VärbamineFaas 2/3
Vanused 35–80 · Kõik sood · Uuendatud 31. aug 2026 · NCT07363694Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.